HMP Global Acquires Neuroscience Education Institute (NEI)

HMP Global Acquires Psychiatry Redefined

September 22, 2025

Healthcare Services

HMP Global has acquired Psychiatry Redefined, a clinician-focused educational platform founded by Dr. James Greenblatt that integrates traditional psychopharmacology with functional, nutritional, and integrative psychiatry. The acquisition expands HMP Global’s psychiatry and behavioral health portfolio and aims to scale whole-patient, personalized psychiatry education to clinicians worldwide.

HMP Global Acquires Drug Channels Institute

January 4, 2024

Healthcare Services

HMP Global has entered into a definitive agreement to acquire Drug Channels Institute (DCI), a provider of pharmaceutical market intelligence and analysis. The acquisition will fold DCI into HMP Market Access Insights to create a new market intelligence division, expanding HMP Global's research capabilities and services for clients across the pharmaceutical ecosystem.

The IMA Group Acquires Albuquerque Neuroscience, Inc.

September 9, 2021

Healthcare Services

The IMA Group has acquired Albuquerque Neuroscience, Inc., a clinical research site specializing in central nervous system (CNS) and general medical condition trials. The acquisition expands IMA Clinical Research's national footprint and deepens its capabilities in psychiatry, Alzheimer's disease and other neuropathic therapeutic areas; financial terms were not disclosed.

MPM BioImpact Takes Reunion Neuroscience Private

June 1, 2023

Biotechnology

Affiliates of biotechnology investor MPM BioImpact agreed to acquire clinical-stage biopharmaceutical company Reunion Neuroscience in an all-cash take-private transaction valued at about US$13.1 million. Reunion shareholders will receive US$1.12 per share in cash; MPM said the acquisition will support advancement of Reunion's lead psychedelic therapeutic RE104 into Phase 2 clinical development.

GE HealthCare Acquires Remaining Stake in Nihon Medi-Physics (NMP)

March 31, 2025

Healthcare Services

GE HealthCare has completed the acquisition of Sumitomo Chemical's remaining 50% stake in Nihon Medi-Physics (NMP), giving GE HealthCare full ownership. The deal brings the Tokyo-based radiopharmaceutical manufacturer into GE HealthCare's Pharmaceutical Diagnostics segment (Kevin O'Neill to lead NMP) to expand its footprint and patient access to molecular imaging agents in Japan and the broader Asian market.

HMH Acquires NWEA

January 10, 2023

Education

Learning technology company Houghton Mifflin Harcourt (HMH) has acquired research and assessment organization NWEA. NWEA will operate as a division of HMH, keeping its MAP Growth assessment brand while integrating assessment insights with HMH curriculum to deliver a connected K–12 instruction and assessment solution.